Explore 3 Stock Ideas & Industry Insights Download Free Report

News

This Penny Stock Jumped 23% Today — Why TELA Bio (NASDAQ:TELA) Named a New CEO

TELA Bio (NASDAQ:TELA) shares closed up 22.51% at $0.91, with a day range of $0.68 to $0.93 on volume of 731,730 shares, after the company announced that its board of directors has appointed Heather Getz as Chief Executive Officer and Director, effective immediately.

Vinay Lochav | 04 August 2026

Why Is Bausch Health (NYSE:BHC) Stock Down 8% After Its Post-Earnings Rally?

Bausch Health (NYSE:BHC) shares closed down 8.00% at $6.44, with a day range of $6.36 to $7.05 on volume of 12.10 million shares. No new macro, sector, or company-specific catalysts were identified for the decline today, suggesting the move reflects profit-taking and consolidation after …

Vinay Lochav | 04 August 2026

ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Surges 27% on Phase 3 Trial Launch and Q2 Results

ORIC Pharmaceuticals (NASDAQ:ORIC) shares surged 27.08% to close at $13.47, with a day range of $10.64 to $13.73 on volume of 4.98 million shares, after the company reported second-quarter financial results and provided operational updates highlighted by the initiation of a pivotal Phase 3 …

Vinay Lochav | 04 August 2026

Penny Stock Adagio Medical (NASDAQ:ADGM) Jumps 76% on First-Patient Treatment Milestone

Adagio Medical Holdings (NASDAQ:ADGM) shares closed up 76.11% at $0.81, with a day range of $0.55 to $1.13 on volume of 467.24 million shares, after the company announced the successful treatment of the first patient with its next-generation vCLAS Ultra system.

Vinay Lochav | 04 August 2026

Why Did Bruker (NASDAQ:BRKR) Stock Plunge 22% Today?

Bruker (NASDAQ:BRKR) shares plunged 21.79% to close at $50.30, with a day range of $50.14 to $56.37 on volume of 8.82 million shares, after the company's second-quarter report revealed a lowered full-year revenue guidance range that overshadowed an otherwise mixed quarter.

Vinay Lochav | 04 August 2026

Pfizer (NYSE:PFE) Stock Closes Higher After Q2 Beat and Raised Guidance

Pfizer (NYSE:PFE) shares closed up 1.52% at $25.41, with a day range of $24.70 to $25.64 on volume of 55.42 million shares, after the company reported second-quarter results that beat Wall Street expectations on both revenue and earnings.

Vinay Lochav | 04 August 2026

Amgen (NASDAQ:AMGN) Stock Closes Up 3% on Strong Q2 Beat and Raised Guidance

Amgen (NASDAQ:AMGN) shares closed up 2.94% at $390.02, with a day range of $376.02 to $390.95 on volume of 3.46 million shares, after the company delivered a strong second-quarter earnings beat that exceeded both revenue and profit expectations.

Vinay Lochav | 04 August 2026

Why Did Gilead Sciences (NASDAQ:GILD) Stock Rise 3% Despite a Massive GAAP Loss?

Gilead Sciences (NASDAQ:GILD) shares closed up 3.14% at $135.27, with a day range of $129.54 to $135.50 on volume of 9.50 million shares, despite the company reporting a substantial GAAP net loss for the second quarter. Investors appeared to focus on the fact that …

Vinay Lochav | 04 August 2026

Why Arxis, Inc. (NASDAQ: ARXS) Stock Just Broke Out to a New 52-Week High

Trend Structure: IPO Breakout, Strong Momentum, and New Highs

Vinay Lochav | 04 August 2026

Semiconductor and Chip-Equipment Names Rally Hard as AMD, TER, and FORM Post Double-Digit Gains, TSEM and LSCC Join the Advance

Advanced Micro Devices, Inc. (NASDAQ: AMD) — Powerful Reversal on Heavy Volume, Reclaiming Both EMAs

Vinay Lochav | 04 August 2026
Support

Hi! How can we help you today?

Loading…